ChristopherLaFargueMDMS

Obstetrics & Gynecology • Houston, TX

Gynecologic Oncology

Clinical Fellow

Join to view full profile

Dr. LaFargue is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. LaFargue's full profile

Already have an account?

Office
1155 Pressler St
Houston, TX 77030
Phone+1 713-563-4539
Is this information wrong?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2017
University of California (Irvine)Residency, Obstetrics and Gynecology, 2013 - 2017
New York Medical CollegeClass of 2013

Certifications & Licensure

TX State Medical License 2019 - 2025
CA State Medical License 2015 - 2024
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Publications & Presentations

PubMed

8 citations
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina ...> ;Nature Communications. 2023 Apr 26
3 citations
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
Christopher J LaFargue, Katelyn F Handley, Nicole D Fleming, Alpa M Nick, Anca Chelariu-Raicu, Bryan Fellman, Tara Castellano, Aiko Ogasawara, Marianne Hom-Tedla, Erin...> ;Gynecologic Oncology. 2022 Apr 1
19 citations
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance.
Shaolin Ma, Lingegowda S. Mangala, W. Hu, Emine Bayaktar, Akira Yokoi, Wei Hu, Sunila Pradeep, Sanghoon Lee, Paul D. Piehowski, Alejandro Villar-Prados, Sherry Y. Wu, ...> ;Cell Reports. 2021 Aug 17
2 citations
Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies.
Emily Hinchcliff, Shannon N. Westin, Graziela Zibetti Dal Molin, Christopher J. LaFargue, Robert L. Coleman> ;International Journal of Gynecological Cancer. 2019 May 22
8 citations
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.
Alejandro Villar-Prados, Sherry Y. Wu, Karem A. Court, Shaolin Ma, Christopher J. LaFargue, Mamur A Chowdhury, Margaret I. Engelhardt, Cristina Ivan, Prahlad T. Ram, Y...> ;Molecular Cancer Therapeutics. 2019 Feb 1
235 citations
Exploring and comparing adverse events between PARP inhibitors.
Christopher J. LaFargue, Graziela Zibetti Dal Molin, Anil K. Sood, Robert L. Coleman> ;The Lancet. Oncology. 2019 Jan 1
2 citations
When Ovarian Cancer Is Not: Characterizing Nonovarian Cancer Pathology in a Laparoscopy-Based Triage System
R.L. Dood, Nicole D. Fleming, Robert L. Coleman, Shannon N. Westin, Olivia D. Lara, Christopher J. LaFargue, Jinsong Liu, Anil K. Sood> ;International Journal of Gynecological Cancer. 2018 Oct 1
20 citations
ADH1B promotes mesothelial clearance and ovarian cancer infiltration
Kshipra M. Gharpure, Olivia D. Lara, Yunfei Wen, Sunila Pradeep, Christopher J. LaFargue, Cristina Ivan, Rajesha Rupaimoole, Wei Hu, Lingegowda S. Mangala, Sherry Y. W...> ;Oncotarget. 2018 May 18
9 citations
The Ecstacy of Gold: Patent Expirations for Trastuzumab, Bevacizumab, Rituximab, and Cetuximab
Tasha Serna-Gallegos, Christopher J. LaFargue, Krishnansu S. Tewari> ;Recent Patents on Biotechnology. 2017 Nov 22
21 citations
Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer.
Christopher J. LaFargue, B.T. Sawyer, Robert E. Bristow> ;Gynecologic Oncology Reports. 2016 Aug 1
2 citations
Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer
Brandon T. Sawyer, Christopher J. LaFargue, Robert E. Bristow> ;Gynecologic Oncology. 2016 Aug 1
1 citations
Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer
Christopher J. LaFargue, Krishnansu S. Tewari> ;Recent Patents on Biotechnology. 2016 Jan 1
12 citations
Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
Christopher J. LaFargue, Robert E. Bristow> ;Gynecologic Oncology. 2015 Sep 1
5 citations
Routine cystoscopy after robotic gynecologic oncology surgery.
My-Linh T. Nguyen, E. Stevens, Christopher J. LaFargue, Michael Karsy, Tarah L. Pua, Constantine Gorelick, Sean S. Tedjarati, T.S. Pradhan> ;JSLS. 2014 Jul 1
5 citations
Grade 1 endometrioid endometrial carcinoma presenting with pelvic bone metastasis: a case report and review of the literature.
My-Linh T. Nguyen, Christopher J. LaFargue, Tarah L. Pua, Sean S. Tedjarati> ;Case Reports in Obstetrics and Gynecology. 2013 Apr 22
211 citations
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
Cristina Magi-Galluzzi, Toyonori Tsusuki, Paul Elson, Kelly Simmerman, Christopher J. LaFargue, Raquel Esgueva, Eric A. Klein, Mark A. Rubin, Ming Zhou> ;The Prostate. 2011 Apr 1
62 citations
Testing mutual exclusivity of ETS rearranged prostate cancer
Maria A. Svensson, Christopher J. LaFargue, Theresa Y. MacDonald, Dorothee Pflueger, Naoki Kitabayashi, Ashley M Santa-Cruz, Karl Garsha, Ubaradka G. Sathyanarayana, J...> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2011 Mar 1
50 citations
ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression
David S. Rickman, Ying bei Chen, Samprit Banerjee, Yihang Pan, Jindan Yu, Terry Vuong, Sven Perner, Christopher J. LaFargue, Kirsten D. Mertz, Sunita R. Setlur, Kanish...> ;Neoplasia. 2010 Dec 1
373 citations
Rearrangements of the RAF Kinase Pathway in Prostate Cancer, Gastric Cancer and Melanoma
Nallasivam Palanisamy, Bushra Ateeq, Shanker Kalyana-Sundaram, Dorothee Pflueger, Kalpana Ramnarayanan, Sunita Shankar, Bo Han, Qi Cao, Xuhong Cao, Khalid Suleman, Cha...> ;Nature Medicine. 2010 Jul 1
122 citations
Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort
Raquel Esgueva, Sven Perner, Christopher J. LaFargue, Veit Scheble, Carsten Stephan, Michael Lein, Florian R. Fritzsche, Manfred Dietel, Glen Kristiansen, Mark A. Rubin> ;Modern Pathology. 2010 Jan 29
742 citations
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass, Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, Roeland Verhaak, So Young Kim, Leslie Wardwell, Pablo Tamayo, Irit Gat-Viks, Alex H. Ramos, Mic...> ;Nature Genetics. 2009 Nov 1
73 citations
Amplification of chromosomal segment 4q12 in non-small cell lung cancer
Alex H. Ramos, Amit Dutt, Craig H. Mermel, Sven Perner, Jeonghee Cho, Christopher J. LaFargue, Laura A. Johnson, Ann Cathrin Stiedl, Kumiko E. Tanaka, Adam J. Bass, Jo...> ;Cancer Biology & Therapy. 2009 Nov 1
14 citations
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
Patrick L. Wagner, Sven Perner, David S. Rickman, Christopher J. LaFargue, Naoki Kitabayashi, Stephen F. Johnstone, Barbara A. Weir, Matthew Meyerson, Nasser K. Altork...> ;American Journal of Clinical Pathology. 2009 Oct 1
92 citations
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
Dorothee Pflueger, David S. Rickman, Andrea Sboner, Sven Perner, Christopher J. LaFargue, Maria A. Svensson, Benjamin J. Moss, Naoki Kitabayashi, Yihang Pan, Alexandre...> ;Neoplasia. 2009 Aug 1
290 citations
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.
Dolores Di Vizio, Jayoung Kim, Martin H. Hager, Matteo Morello, Wei Yang, Christopher J. LaFargue, Lawrence D. True, Mark A. Rubin, Rosalyn M. Adam, Rameen Beroukhim, ...> ;Cancer Research. 2009 Jul 1
Join now to see all